Statin trials have been designed to demonstrate plaque stability rather than regression. That’s why those trials have measured the change in plaque volume relative to the change on placebo –not relative a patient’s own baseline reading as in the AGIX trial.
>> P.S. Some racy ads at i-hub! Looking at an ad for the "hottest" dating site! <<
If you sign up for a paid iHub membership, you won’t have to see those ads
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”